Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05197270
What this trial is testing

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics 215
Testing effectiveness (Phase 2)Study completedNCT00527423
What this trial is testing

Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 157
Large-scale testing (Phase 3)UnknownNCT00370370
What this trial is testing

Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Shahid Beheshti University of Medical Sciences
Post-approval studies (Phase 4)Study completedNCT01464723
What this trial is testing

Study EvAluating Genotypes While Using Lucentis 2

Who this might be right for
Age-Related Macular Degeneration
University of California, San Diego 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 139
Post-approval studies (Phase 4)UnknownNCT00354445
What this trial is testing

A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

Who this might be right for
Age-Related Macular Degeneration (AMD)
Eyetech Pharmaceuticals 1,000
Not applicableStudy completedNCT03833830
What this trial is testing

Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment

Who this might be right for
Neovascular Age-related Macular Degeneration
Dr. med. Katja Hatz 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05904028
What this trial is testing

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Jaeb Center for Health Research 603
Not applicableUnknownNCT03128463
What this trial is testing

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Who this might be right for
Age-Related Macular DegenerationPolypoidal Choroidal VasculopathyPathological Myopia+2 more
Xun Xu 5,000
Large-scale testing (Phase 3)UnknownNCT00710229
What this trial is testing

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Not applicableWithdrawnNCT00447031
What this trial is testing

Combination Therapy for Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Yonsei University
Not applicableStudy completedNCT01404845
What this trial is testing

Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation

Who this might be right for
Exudative Age-related Macular Degeneration
Affordance 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816315
What this trial is testing

Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)

Who this might be right for
Wet Age Related Macular Degeneration
Ollin Biosciences, Inc. 500
Post-approval studies (Phase 4)UnknownNCT01918878
What this trial is testing

Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.

Who this might be right for
Neovascular Age-related Macular Degeneration
Hadassah Medical Organization 48
Testing effectiveness (Phase 2)Study completedNCT00935883
What this trial is testing

Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Philip J. Rosenfeld, MD, PhD 60
Not applicableEnded earlyNCT01337414
What this trial is testing

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Johns Hopkins University 324
Large-scale testing (Phase 3)Study completedNCT03823287
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 671
Large-scale testing (Phase 3)Looking for participantsNCT07516132
What this trial is testing

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Ocular Therapeutix, Inc. 850
Not applicableLooking for participantsNCT07427160
What this trial is testing

Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages

Who this might be right for
AMD - Age-Related Macular Degeneration
Marco Mazzola 60
Large-scale testing (Phase 3)Study completedNCT00599222
What this trial is testing

The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Anders Kvanta 100
Next Page